COPD and co-morbidities: Mortality in COPD patients discharged from hospital: The role of treatment and co-morbidity Respir Res 2006;7:109

摘要: Background The aim of this study was to analyse mortality and associated risk factors, with special emphasis on health status, medications co-morbidity, in patients chronic obstructive pulmonary disease (COPD) that had been hospitalized for acute exacerbation. Methods This prospective included 416 from each the five Nordic countries were followed 24 months. St. George's Respiratory Questionnaire (SGRQ) administered. Information treatment co-morbidity obtained. Results During follow-up 122 (29.3%) died. Patients diabetes an increased rate [HR=2.25 (1.28–3.95)]. Other factors advanced age, low FEV 1 lower status. treated inhaled corticosteroids and/or long-acting beta-2-agonists a death than using neither these types treatment. Conclusion Mortality high after COPD admission, older decreased lung function, status most important factors. Treatment bronchodilators may be COPD.